Found: 77
Select item for more details and to access through your institution.
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 817, doi. 10.1093/oncolo/oyae118
- By:
- Publication type:
- Article
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.
- Published in:
- Oncogene, 2002, v. 21, n. 1, p. 119, doi. 10.1038/sj.onc.1205028
- By:
- Publication type:
- Article
Differential expression of cell adhesion genes: Implications for drug resistance.
- Published in:
- International Journal of Cancer, 2005, v. 113, n. 6, p. 861, doi. 10.1002/ijc.20671
- By:
- Publication type:
- Article
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 6, p. 751, doi. 10.1002/ijc.10131
- By:
- Publication type:
- Article
Clinical applications of serum tumor markers.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Cardiac Involvement with Lymphoma: A Review of the Literature.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 4, p. 249
- By:
- Publication type:
- Article
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 192, doi. 10.1016/j.clpt.2006.05.003
- By:
- Publication type:
- Article
Response: Re: Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 9, p. 718, doi. 10.1093/jnci/djs166
- By:
- Publication type:
- Article
Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 23, p. 1738, doi. 10.1093/jnci/djr386
- By:
- Publication type:
- Article
P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
- Published in:
- International Journal of Cancer, 1991, v. 49, n. 5, p. 696, doi. 10.1002/ijc.2910490512
- By:
- Publication type:
- Article
Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
- Published in:
- International Journal of Cancer, 1991, v. 49, n. 5, p. 688, doi. 10.1002/ijc.2910490511
- By:
- Publication type:
- Article
Perfusion lung scan: an aid in detection of lymphangitic carcinomatosis.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Immunological skin testing and interpretation. A plea for uniformity.
- Published in:
- Cancer (0008543X), 1979, v. 43, n. 6, p. 2306, doi. 10.1002/1097-0142(197906)43:6<2306::AID-CNCR2820430621>3.0.CO;2-K
- By:
- Publication type:
- Article
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 1, p. 39, doi. 10.1007/s10549-023-07131-7
- By:
- Publication type:
- Article
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 39, doi. 10.1007/s10549-023-07131-7
- By:
- Publication type:
- Article
Long‐term follow‐up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2022, v. 126, n. 8, p. 1442, doi. 10.1002/jso.27085
- By:
- Publication type:
- Article
Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients.
- Published in:
- Cancer Reports, 2022, v. 5, n. 9, p. 1, doi. 10.1002/cnr2.1565
- By:
- Publication type:
- Article
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00261
- By:
- Publication type:
- Article
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 2731, doi. 10.2147/CMAR.S211151
- By:
- Publication type:
- Article
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 8, p. 1379, doi. 10.1016/j.molonc.2014.05.001
- By:
- Publication type:
- Article
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 2, p. 256, doi. 10.1111/j.1365-2141.2009.07954.x
- By:
- Publication type:
- Article
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
- Published in:
- Journal of Cellular Biochemistry, 1997, v. 65, n. 4, p. 513, doi. 10.1002/(SICI)1097-4644(19970615)65:4<513::AID-JCB7>3.0.CO;2-R
- By:
- Publication type:
- Article
Variants of uncertain significance in precision oncology: nuance or nuisance?
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 641, doi. 10.1093/oncolo/oyae135
- By:
- Publication type:
- Article
The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Highlights of ASCO 2023.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 739, doi. 10.1093/oncolo/oyad222
- By:
- Publication type:
- Article
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 460, doi. 10.1093/oncolo/oyad023
- By:
- Publication type:
- Article
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 139, doi. 10.1093/oncolo/oyac217
- By:
- Publication type:
- Article
Back to the Future, II.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Oncologist v2.0: Building on a 27-Year Legacy of Accomplishment.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. 517, doi. 10.1093/oncolo/oyac125
- By:
- Publication type:
- Article
Supreme Court and the Practice of Oncology.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Antibiotics and Imiquimod for Cutaneous T‐Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 727, doi. 10.1002/onco.13785
- By:
- Publication type:
- Article
Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP‐35, and a Path Back to the Future.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 274, doi. 10.1002/onco.13681
- By:
- Publication type:
- Article
A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. 89, doi. 10.1002/onco.13677
- By:
- Publication type:
- Article
Emerging Therapeutic Implications of STK11 Mutation: Case Series.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 733, doi. 10.1634/theoncologist.2019-0846
- By:
- Publication type:
- Article
Accrual, Publication Bias, and the Coronavirus in 2020.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1001, doi. 10.1634/theoncologist.2020-0455
- By:
- Publication type:
- Article
Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 132, doi. 10.1634/theoncologist.2019-0264
- By:
- Publication type:
- Article
Publish or Perish v2.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 723, doi. 10.1634/theoncologist.2019-0319
- By:
- Publication type:
- Article
PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 571, doi. 10.1634/theoncologist.2019-0281
- By:
- Publication type:
- Article
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer Research.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1391, doi. 10.1634/theoncologist.2018-0662
- By:
- Publication type:
- Article
Too Many Journals.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 126, doi. 10.1634/theoncologist.2017-0012
- By:
- Publication type:
- Article
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 261, doi. 10.1634/theoncologist.2015-0516
- By:
- Publication type:
- Article
Central Nervous System Metastasis From Breast Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 1, p. 3, doi. 10.1634/theoncologist.2014-0469
- By:
- Publication type:
- Article
Clinical Trial Results: A Clinical Trial Bazaar!
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 313, doi. 10.1634/theoncologist.2014-0091
- By:
- Publication type:
- Article
Clinical Trial Results: Sharing Results, Speeding Discoveries.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1® in Combination With Paclitaxel in Solid Tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1 in Combination With Paclitaxel in Solid Tumors.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Commentary: Troublesome Words, Linguistic Precision, and Medical Oncology.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Tumor Growth Rates Derived from Data for Patients in a Clinical Trial Correlate Strongly with Patient Survival: A Novel Strategy for Evaluation of Clinical Trial Data.
- Published in:
- Oncologist, 2008, v. 13, n. 10, p. 1046, doi. 10.1634/theoncologist.2008-0075
- By:
- Publication type:
- Article